Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Lucid Diagnostics (LUCD) Shares Issued (2022 - 2025)

Lucid Diagnostics' Shares Issued history spans 4 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 306.32% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $3.8 million, up 91.88%, while the annual FY2025 figure was $17000.0, 99.06% down from the prior year.
  • Shares Issued reached $1.8 million in Q4 2025 per LUCD's latest filing, up from $131000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.8 million in Q2 2025 to a low of -$1.1 million in Q2 2022.
  • Average Shares Issued over 4 years is $434153.8, with a median of $187000.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: soared 25166.67% in 2023, then plummeted 93.8% in 2024.
  • A 4-year view of Shares Issued shows it stood at $1000.0 in 2022, then skyrocketed by 151500.0% to $1.5 million in 2023, then plummeted by 70.78% to $443000.0 in 2024, then soared by 306.32% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Shares Issued are $1.8 million (Q4 2025), $131000.0 (Q3 2025), and $1.8 million (Q2 2025).